BlackRock Investment Management, LLC - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 119 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q1 2017. The put-call ratio across all filers is 1.48 and the average weighting 0.0%.

Quarter-by-quarter ownership
BlackRock Investment Management, LLC ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q4 2016$3,453,000
+18.1%
187,464
+21.7%
0.00%0.0%
Q3 2016$2,923,000
+31.1%
154,096
+11.4%
0.00%
+33.3%
Q2 2016$2,230,000
+56.4%
138,352
+16.4%
0.00%
+50.0%
Q1 2016$1,426,000
-15.3%
118,845
+0.5%
0.00%0.0%
Q4 2015$1,683,000
+21.7%
118,254
-0.0%
0.00%0.0%
Q3 2015$1,383,000
-33.3%
118,284
+0.2%
0.00%
-33.3%
Q2 2015$2,075,000
+408.6%
118,046
+332.8%
0.00%
+200.0%
Q1 2015$408,000
+36.5%
27,277
+5.8%
0.00%
Q4 2014$299,000
+1.7%
25,774
+2.2%
0.00%
Q3 2014$294,00025,2230.00%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q1 2017
NameSharesValueWeighting ↓
EAM Investors, LLC 173,018$3,187,0000.42%
GLOBEFLEX CAPITAL L P 50,686$934,0000.23%
KALMAR INVESTMENTS INC /DE/ 240,648$4,433,0000.23%
ESSEX INVESTMENT MANAGEMENT CO LLC 63,661$1,173,0000.19%
OBERWEIS ASSET MANAGEMENT INC/ 27,200$501,0000.15%
Invictus RG 11,950$220,0000.15%
ACADIAN ASSET MANAGEMENT LLC 1,502,151$27,668,0000.13%
FOX RUN MANAGEMENT, L.L.C. 12,600$232,0000.12%
Piermont Capital Management Inc. 26,153$482,0000.11%
FEDERATED HERMES, INC. 1,344,684$24,769,0000.07%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders